PSGBI Committee

Pancreatic Society of Great Britain and Ireland

The Pancreatic Society aims to promote education, training, research and development in understanding and managing pancreatic conditions. It endeavours to increase both professional and public awareness of the prevalence of pancreatic conditions and the facilities that are available for its management. The Society is involved in all aspects of pancreatic conditions and through the work of the Committee

Contents

  1. Committee Members
  2. BSG Committee members

Committee Members

 

Prof Mark A Taylor CStJ PhD FRCSI FRCS(Eng) FRCS(Gen Surg) (President)  is a Consultant HPB Surgeon at the Mater Hospital, Belfast Health and Social Care Trust. He trained in Belfast and at the Regional HPB and Transplant Unit in Edinburgh. His Doctorate of Philosophy was in the pathophysiology of obstructive jaundice. He is the President of GBI Hepato-pancreato-biliary Association (GBIHPBA), President Elect of the Pancreatic Society of Great Britain and Ireland (PSGBI), Lead for Education, Research and Training for the Association of Upper Gastro- Intestinal Surgeons (AUGIS) and on the Medical Advisory Board of Bowel Cancer UK.  In 2016, he was appointed by the Health Minister to an independent Expert panel tasked with Reconfiguration of Health and Social care in Northern Ireland. In 2017 he was appointed to the Transformation Implementation Group (TIG) Department of Health. In 2018 he was appointed the Director of Professional Affairs (NI) for the Royal College of Surgeons of England. He has published extensively in the field of Hepatobiliary Surgery. He is a Visiting Professor at Ulster University. He is passionate about innovation, change and collective leadership within the HSCNI . He is a trustee of St. John Ambulance and a keen cyclist. 

Bill Greenhalf (Past President) William (Bill) Greenhalf is a Professor of Molecular Oncology in the Department of Molecular and Clinical Cancer Medicine at the University of Liverpool. He is the lead scientist of the European Registry of Hereditary Pancreatitis and Familial Pancreatic Cancer (EUROPAC), the Director of the Liverpool Good Clinical Practice Laboratory (GCPLab) facility and is the non-clinical lead for the Liverpool Experimental Cancer Medicines Centre (ECMC). Bill was awarded his PhD from the University of Manchester in 1990 and has since worked for the State University of São Paulo (UNESP) in Brazil, Ciba-Geigy and then Novartis in Basle Switzerland, before coming to Liverpool in 1997. He has served on the committees of both the PSGBI and the European Pancreatic Club and was elected to be the president of the PSGBI in 2019.

 

Dr Matthew Huggett (Secretary) is a Consultant Gastroenterologist and HPB Physician at St James’s University Hospital, Leeds. He has a major interest in pancreaticobiliary disease and performs advanced endoscopy including EUS and ERCP. His training involved experience at major centres in London including the Royal Free Hospital, King’s Liver Unit and St Mary’s Hospital; followed by a fellowship in HPB endoscopy at the Freeman Hospital in Newcastle. His ongoing clinical and research interests include interventional EUS/ERCP, pancreatic neoplasia, chronic pancreatitis, autoimmune pancreatitis and sphincter of oddi dysfunction. He was awarded a PhD from University College London in 2014 following his work into DNA replication in pancreatic cancer. He is involved in training UK and overseas doctors in advanced endoscopy. He was appointed Honorary Secretary of the Pancreatic Society of Great Britain and Ireland in 2017.

 

Keith Roberts (Treasurer) Keith is consultant HPB and liver transplant surgeon at University Hospitals Birmingham NHS Foundation Trust. He is the pancreas surgery lead for the Royal College of Surgeons of England. His research focuses upon improving pathways and outcomes for those with pancreatic cancer and upon pancreatic exocrine insufficiency. He is chair of IMPROVE Panc, a multidisciplinary pancreas surgery research team.

 

 

Chris Briggs is a Consultant HPB and Sarcoma surgeon at University Hospitals Plymouth. He qualified from the University of Sheffield medical school at the turn of the millennium and trained in general surgery in the South Yorkshire region. He spent two years in Leicester studying for a research MD and then sub-specialised in Hepatobiliary and Pancreatic surgery, working on the Sheffield liver and pancreatic unit for two and a half years and a year at the Leeds liver transplantation centre. He completed his training in Plymouth. He is now the Clinical Director of the Plymouth HPB unit and a Pancreatic Society council member.

 

Simon Mark EVERETT  - MbChB, MD, FRCP  Born and raised in the South of England, I trained in Leeds and was appointed as Consultant Gastroenterologist in Leeds Teaching Hospitals Trust in 2002.  I have held various clinical leadership roles including Clinical Lead for Endoscopy since 2007 - 2018 and Clinical Director roles from 2009 - 2015. My clinical interests include IBD and interventional endoscopy, particularly ERCP, EUS and management of stricturing diseases. I sat on the BSG endoscopy committee between 2012-2015, during which I was first author on the BSG guidelines for informed consent, and am a current active participant in the ESGE guidelines committee. The rest of my time is spent on bicycles, fell running with my dog, skiing or with my family.

 

 

Lynne McCallum Clinical Nurse Specialist Lynne currently is the nurse specialist for the north of England for Pancreatic Cancer UK, prior to this appointment she was the HPB and NET CNS at the Christie in Manchester and has supported those affected with a pancreatic malignancy since she qualified at a nurse in 2003. Her interests lie in nutritional well-being in pancreatic cancer & in 2014 presented work she had undertaken in this field at ESMO. She has particular interest in raising the profile of the CNS whilst supporting & developing the role of the HPB CNS across the UK. She helped to set up the National Hpb Nurse Group which was founded in 2017 and was developed to offer a platform for the HPB CNS community to meet, have peer to peer support, share nurse research & practice innovation and provides professional development for this group of senior nurses.

 

Oonagh Griffin Dietician Oonagh has worked as Senior Pancreatic Dietitian at the National Surgical Centre for Pancreatic Cancer at St Vincent’s University Hospital, since 2011, establishing a specialist dietetic service for people with pancreatic cancer.  A graduate of Dublin Institute of Technology/Trinity College Dublin, she initially worked at the Mater Misericordiae University Hospital Hospital in Dublin before moving to the UK to gain experience in oncology. She spent over 7 years working in the NHS from 2003 to 2010, including Addenbrooke’s Hospital in Cambridge and St Bartholomew’s in London. Her final role in the NHS was as Dietetic Team Leader at the Royal Marsden Hospital where she was selected for the National Cancer Leadership Programme. Oonagh is vice-chair of the Nutrition Interest Group of the Pancreatic Society of Great Britain and Ireland (PSGBI), co-ordinating educational activities and representing the group at PSGBI Council since 2017. In 2015 she received a Health Research Board Research Training Fellowship, allowing her to commence her PhD at Trinity College Dublin. Her research interests include cancer cachexia, pancreatic exocrine insufficiency, and body composition assessment.

 

Professor Giuseppe Garcea is a consultant HPB surgeon at the University Hospitals of Leicester appointed in 2011. He is the clinical director for Cancer, Palliative Care, Haematology, Urology, Gastroenterology and GI surgery and holds an honorary chair with the University of Leicester in Cancer Studies

 

 

 

Manu Nayar Co opted EUS user group is a full time Consultant Gastroenterologist at the Freeman Hospital, Newcastle upon Tyne since 2008. His subspecialty area of interest is hepatobiliary and pancreatic medicine. This includes endoscopic management i.e. therapeutic ERCP and endoscopic ultrasound and also management of benign & malignant pancreaticobiliary diseases. He is well published in peer reviewed journals in this area. He has been the director of endoscopy and the training centre lead for Newcastle upon Tyne Hospital. He is the President of the UK & Ireland EUS society. He is a committee member of the pancreatic society of GB & Ireland, the BSG endoscopy section & the European EUS organisation. He organises an annual national course for ERCP and EUS for nurses and is the course director the JAG EUS basic skills course. He is a course director of various national meetings & is a faculty on multiple national live endoscopy events.  He is involved in national trials relating to pancreaticobiliary (PB) endoscopy and is well published in this field.

 

Back to top

BSG Committee members

Andrew Hopper Chairman  Professor Andrew Hopper is a Gastroenterology Consultant and Honorary Professor at Sheffield Teaching Hospitals and Sheffield University.  After an initial Initial MD investigating the endoscopic diagnosis of small bowel disease, Prof Hopper went on to perform a 18 month advanced endoscopy fellowship at Westmead University Hospital, Sydney, Australia in endoscopic luminal mucosal resection coupled with diagnostic and therapeutic endoscopic ultrasound (EUS).  Prof Hopper currently  provides  specialist therapeutic endoscopy and EUS services to the pancreatic and upper gastrointestinal networks (benign and cancer) for the South Yorkshire region.

Professor Hopper became the chair for the Pancreas section of the British Society of Gastroenterology (Sept 2017) and has active research and fellow programme with 70 peer review publications including chronic pancreatits, pancreatic exocrine insufficiency, endoscopic giant ampullary adenoma removal and complications of acute pancreatitis. 

 

Dr Bharat Paranandi is a Gastroenterologist with a sub-specialist interest in HPB medicine and interventional endoscopy - Endoscopic Ultrasound (EUS), Endoscopic retrograde cholangiopancreatography (ERCP) and enteral stenting. He completed his GI training in North East London and Nottingham and then undertook a series of advanced subspecialty fellowships at Addenbrookes Cambridge (Hepatology/ Transplant), UCLH London (ERCP) and Freeman Hospital Newcastle (EUS/ERCP). His main clinical interests include acute, chronic and autoimmune pancreatitis, Sphincter of Oddi dysfunction and interventional EUS/ERCP. He is involved in a number of active clinical trials and is also passionate about endoscopy training, postgraduate medical education and educational course development. He a core member of the Yorkshire school of endoscopy training (YSET), sits on the pancreas section of the BSG, is a core member of the PSGBI and is Secretary for the UK and Ireland EUS users group (UKIEUS).

 

Dr John Leeds is a Consultant Gastroenterologist and Pancreaticobiliary Physician at the Freeman Hospital in Newcastle Upon Tyne with experience in advanced endoscopy including EUS guided sampling and therapeutics, biliary manometry, biliary RFA and Spyglass. He was also part of the team that set up and ran the multidisciplinary chronic pancreatitis clinic. He has published over 40 papers and continues to contribute to the area of pancreaticobiliary medicine. His main areas of interest are advanced EUS/ERCP, exocrine pancreatic disease and endoscopic resection techniques.

 

 

Sharan Shetty Dr Shetty is a Consultant Gastroenterologist and Interventional endoscopist at Dudley group of hospitals NHS foundation trust. He trained both in India (Mumbai) and UK (Gloucester/Bristol). During his training he has worked on the research projects on focal active colitis and interleukins in acute pancreatitis. He leads Upper GI and Hepatobiliary MDT at the trust and also a national Bowel cancer screening colonoscopist. His main interests are interventional endoscopy (ERCP,EUS and EMR etc) and pancreatico-biliary diseases. 

 

 

Nadeem Tehami is a Consultant Hepatologist and and HPB Physician at University Hospital Southampton NHS Foundation Trust. He trained in major teaching hospitals of London, Glasgow and Midlands. He completed a HPB endoscopy fellowship and a liver transplant module from University Hospitals Birmingham NHS Foundations trust. He is interested in the clinical and research aspects of hepatopancreaticobiliary diseases and advanced endoscopy (EUS and ERCP). 

 

 

 

Dr Vikramjit Mitra (MBBS, FRCP, PG Cert. Clinical Education) is a consultant gastroenterologist with special interest in pancreatico-biliary (PB) medicine and advanced endoscopy (EUS, ERCP, EMR and enteral stenting) at University Hospital of North Tees. He completed gastroenterology training in the Northern Deanery followed by a fellowship in PB endoscopy at the Freeman Hospital in Newcastle. He has been involved in the development of HPB services in Teesside (based on hub & spoke model of care). His interests include medical education, development of educational courses, endoscopy training and research in pancreatico-biliary medicine. He is a core member of the Northern School of Endoscopy and has been a faculty in JAG approved training courses. In 2018, he joined as a member of the Pancreas Section of the British Society of Gastroenterology (BSG) and chairs the Pancreas Research Group in the BSG

 

Emmanuel Selvaraj Trainee Rep

Emmanuel Selvaraj was elected the trainee representative in 2018 and is a Specialist Training Registrar in the Oxford Deanery. He is currently out-of-programme undertaking a PhD with the University of Oxford investigating the role of quantitative magnetic resonance imaging in liver and pancreatobiliary diseases. He is also training in ERCP/EUS alongside his research.

 

 

Andrew Hart Co opted APPG is Professor of Gastroenterology at Norwich Medical School. His research interests are investigating the aetiology of pancreatic cancer in the EPIC-Norfolk cohort study, focusing on the role of diet.  Professor Hart is the chief investigator of the BAC-PAC Study - Best Analgesia Control in Patients with Pancreatic AdenoCarcinoma. The first stage of this research is an NIHR funded feasibility study of the early use of EUS-CPN for early pain relief, which will inform the development of a future randomised controlled trial of its use. This work is endorsed and supported by both the PSGBI and British Society of Gastroenterology. Professor Hart has contributed to compiling a series of articles on many aspects of medical pancreatology, published in Gut's sister clinical journal - Frontline Gastroenterology. He was President of the PSGBI in 2015, and currently represents the Society at the All Party Parliamentary Committee on Pancreatic Cancer in Westminster.     

Back to top